| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.41B | 25.20B | 22.06B | 20.43B | 19.70B | 17.93B |
| Gross Profit | 8.15B | 7.33B | 6.41B | 5.75B | 5.37B | 4.82B |
| EBITDA | 7.41B | 7.20B | 6.46B | 5.72B | 5.45B | 4.82B |
| Net Income | 2.79B | 2.71B | 2.75B | 2.30B | 2.24B | 1.82B |
Balance Sheet | ||||||
| Total Assets | 45.70B | 45.84B | 44.57B | 32.82B | 31.37B | 29.10B |
| Cash, Cash Equivalents and Short-Term Investments | 158.00M | 201.00M | 414.00M | 458.00M | 351.00M | 118.00M |
| Total Debt | 22.89B | 22.91B | 23.90B | 16.23B | 14.98B | 13.40B |
| Total Liabilities | 35.68B | 35.84B | 36.31B | 25.93B | 24.50B | 21.97B |
| Stockholders Equity | 10.02B | 9.99B | 8.25B | 6.90B | 6.85B | 7.12B |
Cash Flow | ||||||
| Free Cash Flow | 3.29B | 2.82B | 2.16B | 1.82B | 1.95B | 2.43B |
| Operating Cash Flow | 6.34B | 6.04B | 5.39B | 4.72B | 4.54B | 4.34B |
| Investing Cash Flow | -3.47B | -3.57B | -10.60B | -3.09B | -3.06B | -1.89B |
| Financing Cash Flow | -2.96B | -2.67B | 5.16B | -1.52B | -1.22B | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $62.67B | 28.56 | 18.12% | 1.11% | 3.19% | 5.11% | |
69 Neutral | $14.83B | 37.53 | 14.37% | ― | 1.90% | 2.13% | |
67 Neutral | $86.10B | 30.52 | 28.85% | 1.50% | 10.87% | 4.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $5.36B | 731.09 | 0.46% | ― | 14.92% | -48.77% | |
50 Neutral | $1.76B | -10.14 | -54.89% | ― | -2.08% | -34.89% |